Effects of genetic and nongenetic factors on hyperuricemia in Chinese patients with coronary artery disease.
Weixia ZhangYiwen JinJuan LiJingjing HuangHefeng ChenPublished in: Pharmacogenomics (2021)
Aim: The relationship between hyperuricemia and polymorphisms of transporter genes in coronary artery disease (CAD) patients in China remains unclear. Materials & methods: A total of 258 hyperuricemia patients with CAD and 242 control patients with CAD were recruited in this case-control study. Twenty-four SNPs in genes of ABCG2, PDZK1, URAT1, OAT4, GLUT9, ABCC4, NPT1 and NPT4 were genotyped using direct sequencing in all subjects. Results: The mutation of ABCG2 rs2231142 locus increases the risk of hyperuricemia, and there is a gene dose effect in the influence of mutant heterozygotes and homozygotes. rs3825017 in URAT1 and rs62293298 in GLUT9 were also confirmed to be associated with hyperuricemia. Conclusion: Age, weight, creatinine clearance rate, diuretics and SNPs on ABCG2, URAT1 and GLUT9 were all risk factors of hyperuricemia.
Keyphrases
- uric acid
- coronary artery disease
- genome wide
- metabolic syndrome
- risk factors
- end stage renal disease
- dna methylation
- genome wide identification
- copy number
- percutaneous coronary intervention
- newly diagnosed
- ejection fraction
- chronic kidney disease
- cardiovascular events
- body mass index
- prognostic factors
- peritoneal dialysis
- cardiovascular disease
- left ventricular
- transcription factor
- body weight
- cancer stem cells